Companies/EU/VVY

VIVORYON THERAPEUTICS N.V.

Last · Amsterdam€1.13+0.000000004768 (+0.00%)stale · yahoo · 150h ago
Market cap€33.5M29.6M sh
P/E · TTM-4.9fwd -3.6 · eps -0.23 · loss
Beta1.45vs S&P 500
Div yield—annual · TTM
52w range
€1.00€1.84
Volume20.5Ksession

Issuer

Legal nameVIVORYON THERAPEUTICS N.V.
HQEurope (EU)
ListingEU VVY
ISINNL00150002Q7
LEI3912004AMB0KGZXZYJ15
SectorHealthcare
IndustryBiotechnology & Medical Research
CurrencyEUR
Entity registryisin:NL00150002Q7
Websitewww.vivoryon.com
LinkedIn
Employees13
AddressVivoryon Therapeutics NV Weinbergweg 22 06120, Halle +49 345 55599-00
Loading chart…

Upcoming earnings

1 event
4:30 PM UTC+1
Period
Sep 2026
Est. EPS
—
Est. revenue
0
View financial calendar →

Earnings transcripts

1 recent

Press & signals

3 recent
  • GlobeNewswire

    Vivoryon Therapeutics N.V. to Hold its 2026 Annual General Meeting on September 29, 2026

  • GlobeNewswire

    Vivoryon Therapeutics N.V. Reports H1 2026 Financial Results and Provides Business Update

  • GlobeNewswire

    Vivoryon Therapeutics N.V. to Report H1 2026 Financial Results and Business Updates on August 6, 2026; Annual General Meeting Planned for End of September 2026

Documents

FormReporting forFiledFlags
interim reportPress ReleaseIR
—2026-08-060
interim reportPresentationIR
—2026-08-060
interim reportInterim Management Report June 30, 2026IR
—2026-06-300
press releaseIR
—2026-06-110
press releaseIR
—2026-04-230
Showing 5 of 112 filings